Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Requirement of bic/microRNA-155 for Normal Immune Function
Antony Rodriguez,1*
Elena Vigorito,2*
Simon Clare,1
Madhuri V. Warren,1,3
Philippe Couttet,1
Dalya R. Soond,2
Stijn van Dongen,1
Russell J. Grocock,1
Partha P. Das,4
Eric A. Miska,4
David Vetrie,1
Klaus Okkenhaug,2
Anton J. Enright,1
Gordon Dougan,1
Martin Turner,2
Allan Bradley1
Abstract:
MicroRNAs are a class of small RNAs that are increasingly beingrecognized as important regulators of gene expression. Althoughhundreds of microRNAs are present in the mammalian genome, geneticstudies addressing their physiological roles are at an earlystage. We have shown that mice deficient for bic/microRNA-155are immunodeficient and display increased lung airway remodeling.We demonstrate a requirement of bic/microRNA-155 for the functionof B and T lymphocytes and dendritic cells. Transcriptome analysisof bic/microRNA-155deficient CD4+ T cells identifieda wide spectrum of microRNA-155regulated genes, includingcytokines, chemokines, and transcription factors. Our work suggeststhat bic/microRNA-155 plays a key role in the homeostasis andfunction of the immune system.
1 The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK. 2 Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, CB2 4AT, UK. 3 Department of Pathology, Addenbroke's Hospital, University of Cambridge, Cambridge, CB2 2QQ, UK. 4 Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QN, UK.
* These authors contributed equally to this work
To whom correspondence should be addressed: abradley{at}sanger.ac.uk (A.B.); martin.turner{at}bbsrc.ac.uk (M.T.)
The editors suggest the following Related Resources on Science sites:
In Science Magazine
RESEARCH ARTICLES
Eva van Rooij, Lillian B. Sutherland, Xiaoxia Qi, James A. Richardson, Joseph Hill, and Eric N. Olson (27 April 2007) Science316 (5824), 575.
[DOI: 10.1126/science.1139089] |Abstract »|Full Text »|PDF »|Supporting Online Material »
In Science Signaling
PERSPECTIVES
James E. Dahlberg and Elsebet Lund (22 May 2007) Sci. STKE2007 (387), pe25.
[DOI: 10.1126/stke.3872007pe25] |Abstract »|Full Text »|PDF »
EDITORS' CHOICE
Stephen Simpson (1 May 2007) Sci. STKE2007 (384), tw152.
[DOI: 10.1126/stke.3842007tw152] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Autoantibody Induction by DNA-Containing Immune Complexes Requires HMGB1 with the TLR2/MicroRNA-155 Pathway.
Z. Wen, L. Xu, X. Chen, W. Xu, Z. Yin, X. Gao, and S. Xiong (2013)
J. Immunol.
190, 5411-5422
|Abstract »|Full Text »|PDF »
Mmu-microRNA-200a Overexpression Leads to Implantation Defect by Targeting Phosphatase and Tensin Homolog in Mouse Uterus.
L.-J. Shen, J.-L. He, D.-H. Yang, Y.-B. Ding, X.-M. Chen, Y.-Q. Geng, S.-J. Liu, X.-Q. Liu, and Y.-X. Wang (2013)
Reproductive Sciences
|Abstract »|Full Text »|PDF »
Stage-specific regulation of natural killer cell homeostasis and response against viral infection by microRNA-155.
C. L. Zawislak, A. M. Beaulieu, G. B. Loeb, J. Karo, D. Canner, N. A. Bezman, L. L. Lanier, A. Y. Rudensky, and J. C. Sun (2013)
PNAS
110, 6967-6972
|Abstract »|Full Text »|PDF »
Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells.
R. Trotta, L. Chen, S. Costinean, S. Josyula, B. L. Mundy-Bosse, D. Ciarlariello, C. Mao, E. L. Briercheck, K. K. McConnell, A. Mishra, et al. (2013)
Blood
121, 3126-3134
|Abstract »|Full Text »|PDF »
Combined Serum CA19-9 and miR-27a-3p in Peripheral Blood Mononuclear Cells to Diagnose Pancreatic Cancer.
W.-S. Wang, L.-X. Liu, G.-P. Li, Y. Chen, C.-Y. Li, D.-Y. Jin, and X.-L. Wang (2013)
Cancer Prevention Research
6, 331-338
|Abstract »|Full Text »|PDF »
MicroRNAs and respiratory diseases.
H. Rupani, T. Sanchez-Elsner, and P. Howarth (2013)
Eur. Respir. J.
41, 695-705
|Abstract »|Full Text »|PDF »
Enhanced Susceptibility to Citrobacter rodentium Infection in MicroRNA-155-Deficient Mice.
S. Clare, V. John, A. W. Walker, J. L. Hill, C. Abreu-Goodger, C. Hale, D. Goulding, T. D. Lawley, P. Mastroeni, G. Frankel, et al. (2013)
Infect. Immun.
81, 723-732
|Abstract »|Full Text »|PDF »
What is causing my arthritis, doctor? A glimpse beyond the usual suspects in the pathogenesis of rheumatoid arthritis.
MicroRNA miR-155 Affects Antiviral Effector and Effector Memory CD8 T Cell Differentiation.
C.-Y. Tsai, S. R. Allie, W. Zhang, and E. J. Usherwood (2013)
J. Virol.
87, 2348-2351
|Abstract »|Full Text »|PDF »
Genome-Wide Analyses of Amphioxus MicroRNAs Reveal an Immune Regulation via miR-92d Targeting C3.
R. Yang, T. Zheng, X. Cai, Y. Yu, C. Yu, L. Guo, S. Huang, W. Zhu, R. Zhu, Q. Yan, et al. (2013)
J. Immunol.
190, 1491-1500
|Abstract »|Full Text »|PDF »
T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire.
Y. Bronevetsky, A. V. Villarino, C. J. Eisley, R. Barbeau, A. J. Barczak, G. A. Heinz, E. Kremmer, V. Heissmeyer, M. T. McManus, D. J. Erle, et al. (2013)
J. Exp. Med.
210, 417-432
|Abstract »|Full Text »|PDF »
MicroRNAs in Immune Response and Macrophage Polarization.
Micro-RNA 155 Is Required for Optimal CD8+ T Cell Responses to Acute Viral and Intracellular Bacterial Challenges.
E. F. Lind, A. R. Elford, and P. S. Ohashi (2013)
J. Immunol.
190, 1210-1216
|Abstract »|Full Text »|PDF »
Potential Function of miRNAs in Herpetic Stromal Keratitis.
S. Mulik, S. Bhela, and B. T. Rouse (2013)
Invest. Ophthalmol. Vis. Sci.
54, 563-573
|Abstract »|Full Text »|PDF »
In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors.
E. Fonte, B. Apollonio, L. Scarfo, P. Ranghetti, C. Fazi, P. Ghia, F. Caligaris-Cappio, and M. Muzio (2013)
Clin. Cancer Res.
19, 367-379
|Abstract »|Full Text »|PDF »
Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing.
L. N. Schulte, A. J. Westermann, and J. Vogel (2013)
Nucleic Acids Res.
41, 542-553
|Abstract »|Full Text »|PDF »
BCL6 positively regulates AID and germinal center gene expression via repression of miR-155.
K. Basso, C. Schneider, Q. Shen, A. B. Holmes, M. Setty, C. Leslie, and R. Dalla-Favera (2012)
J. Exp. Med.
209, 2455-2465
|Abstract »|Full Text »|PDF »
miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the E{micro}-miR-155 transgenic mouse model.
S. K. Sandhu, S. Volinia, S. Costinean, M. Galasso, R. Neinast, R. Santhanam, M. R. Parthun, D. Perrotti, G. Marcucci, R. Garzon, et al. (2012)
PNAS
109, 20047-20052
|Abstract »|Full Text »|PDF »
Essential Role of MicroRNA-155 in Regulating Endothelium-Dependent Vasorelaxation by Targeting Endothelial Nitric Oxide Synthase.
H.-X. Sun, D.-Y. Zeng, R.-T. Li, R.-P. Pang, H. Yang, Y.-L. Hu, Q. Zhang, Y. Jiang, L.-Y. Huang, Y.-B. Tang, et al. (2012)
Hypertension
60, 1407-1414
|Abstract »|Full Text »|PDF »
Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies.
J. G. Foster, M. D. Blunt, E. Carter, and S. G. Ward (2012)
Pharmacol. Rev.
64, 1027-1054
|Abstract »|Full Text »|PDF »
Expression, Circulation, and Excretion Profile of MicroRNA-21, -155, and -18a Following Acute Kidney Injury.
J. Saikumar, D. Hoffmann, T.-M. Kim, V. R. Gonzalez, Q. Zhang, P. L. Goering, R. P. Brown, V. Bijol, P. J. Park, S. S. Waikar, et al. (2012)
Toxicol. Sci.
129, 256-267
|Abstract »|Full Text »|PDF »
miR-146a controls the resolution of T cell responses in mice.
L. Yang, M. P. Boldin, Y. Yu, C. S. Liu, C.-K. Ea, P. Ramakrishnan, K. D. Taganov, J. L. Zhao, and D. Baltimore (2012)
J. Exp. Med.
209, 1655-1670
|Abstract »|Full Text »|PDF »
Decreased microRNA-155 Expression in Ocular Behcet's Disease but Not in Vogt Koyanagi Harada Syndrome.
Q. Zhou, X. Xiao, C. Wang, X. Zhang, F. Li, Y. Zhou, A. Kijlstra, and P. Yang (2012)
Invest. Ophthalmol. Vis. Sci.
53, 5665-5674
|Abstract »|Full Text »|PDF »
Knocking Out Viral Myocarditis: Reality or a MiRage?.
X. Sun and M. W. Feinberg (2012)
Circ. Res.
111, 388-391
|Full Text »|PDF »
MicroRNA Profiling Identifies MicroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction During Acute Viral Myocarditis.
M. F. Corsten, A. Papageorgiou, W. Verhesen, P. Carai, M. Lindow, S. Obad, G. Summer, S. L. M. Coort, M. Hazebroek, R. van Leeuwen, et al. (2012)
Circ. Res.
111, 415-425
|Abstract »|Full Text »|PDF »
Identification of Resting and Type I IFN-Activated Human NK Cell miRNomes Reveals MicroRNA-378 and MicroRNA-30e as Negative Regulators of NK Cell Cytotoxicity.
P. Wang, Y. Gu, Q. Zhang, Y. Han, J. Hou, L. Lin, C. Wu, Y. Bao, X. Su, M. Jiang, et al. (2012)
J. Immunol.
189, 211-221
|Abstract »|Full Text »|PDF »
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma.
I. A. Babar, C. J. Cheng, C. J. Booth, X. Liang, J. B. Weidhaas, W. M. Saltzman, and F. J. Slack (2012)
PNAS
109, E1695-E1704
|Abstract »|Full Text »|PDF »
MicroRNA-155 Is Required for Mycobacterium bovis BCG-Mediated Apoptosis of Macrophages.
D. S. Ghorpade, R. Leyland, M. Kurowska-Stolarska, S. A. Patil, and K. N. Balaji (2012)
Mol. Cell. Biol.
32, 2239-2253
|Abstract »|Full Text »|PDF »
Identification of microRNA-regulated gene networks by expression analysis of target genes.
V. A. Gennarino, G. D'Angelo, G. Dharmalingam, S. Fernandez, G. Russolillo, R. Sanges, M. Mutarelli, V. Belcastro, A. Ballabio, P. Verde, et al. (2012)
Genome Res.
22, 1163-1172
|Abstract »|Full Text »|PDF »
MicroRNA-494 Is Required for the Accumulation and Functions of Tumor-Expanded Myeloid-Derived Suppressor Cells via Targeting of PTEN.
Y. Liu, L. Lai, Q. Chen, Y. Song, S. Xu, F. Ma, X. Wang, J. Wang, H. Yu, X. Cao, et al. (2012)
J. Immunol.
188, 5500-5510
|Abstract »|Full Text »|PDF »
Regulation of acute graft-versus-host disease by microRNA-155.
P. Ranganathan, C. E. A. Heaphy, S. Costinean, N. Stauffer, C. Na, M. Hamadani, R. Santhanam, C. Mao, P. A. Taylor, S. Sandhu, et al. (2012)
Blood
119, 4786-4797
|Abstract »|Full Text »|PDF »
microRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination.
M. P. Mycko, M. Cichalewska, A. Machlanska, H. Cwiklinska, M. Mariasiewicz, and K. W. Selmaj (2012)
PNAS
109, E1248-E1257
|Abstract »|Full Text »|PDF »
miR-155 regulates IFN-{gamma} production in natural killer cells.
R. Trotta, L. Chen, D. Ciarlariello, S. Josyula, C. Mao, S. Costinean, L. Yu, J. P. Butchar, S. Tridandapani, C. M. Croce, et al. (2012)
Blood
119, 3478-3485
|Abstract »|Full Text »|PDF »
Reprogramming Tumor-Associated Dendritic Cells In Vivo Using miRNA Mimetics Triggers Protective Immunity against Ovarian Cancer.
J. R. Cubillos-Ruiz, J. R. Baird, A. J. Tesone, M. R. Rutkowski, U. K. Scarlett, A. L. Camposeco-Jacobs, J. Anadon-Arnillas, N. M. Harwood, M. Korc, S. N. Fiering, et al. (2012)
Cancer Res.
72, 1683-1693
|Abstract »|Full Text »|PDF »
Non-cardiomyocyte microRNAs in heart failure.
A. J. Tijsen, Y. M. Pinto, and E. E. Creemers (2012)
Cardiovasc Res
93, 573-582
|Abstract »|Full Text »|PDF »
Breakdown in Peripheral Tolerance in Type 1 Diabetes in Mice and Humans.
L. T. Jeker, H. Bour-Jordan, and J. A. Bluestone (2012)
Cold Spring Harb Perspect Med
2, a007807
|Abstract »|Full Text »|PDF »
MicroRNAs are shaping the hematopoietic landscape.
miR-155 regulates HGAL expression and increases lymphoma cell motility.
L. N. Dagan, X. Jiang, S. Bhatt, E. Cubedo, K. Rajewsky, and I. S. Lossos (2012)
Blood
119, 513-520
|Abstract »|Full Text »|PDF »
Genetic screen identifies microRNA cluster 99b/let-7e/125a as a regulator of primitive hematopoietic cells.
A. Gerrits, M. A. Walasek, S. Olthof, E. Weersing, M. Ritsema, E. Zwart, R. van Os, L. V. Bystrykh, and G. de Haan (2012)
Blood
119, 377-387
|Abstract »|Full Text »|PDF »
Integrative Deep Sequencing of the Mouse Lung Transcriptome Reveals Differential Expression of Diverse Classes of Small RNAs in Response to Respiratory Virus Infection.
X. Peng, L. Gralinski, M. T. Ferris, M. B. Frieman, M. J. Thomas, S. Proll, M. J. Korth, J. R. Tisoncik, M. Heise, S. Luo, et al. (2011)
mBio
2, e00198-11
|Abstract »|Full Text »|PDF »
MicroRNAs Regulate Dendritic Cell Differentiation and Function.
M. L. Turner, F. M. Schnorfeil, and T. Brocker (2011)
J. Immunol.
187, 3911-3917
|Abstract »|Full Text »|PDF »
MicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1{alpha} Activity during Prolonged Hypoxia.
U. Bruning, L. Cerone, Z. Neufeld, S. F. Fitzpatrick, A. Cheong, C. C. Scholz, D. A. Simpson, M. O. Leonard, M. M. Tambuwala, E. P. Cummins, et al. (2011)
Mol. Cell. Biol.
31, 4087-4096
|Abstract »|Full Text »|PDF »
MicroRNA-155 Is Essential for the T Cell-Mediated Control of Helicobacter pylori Infection and for the Induction of Chronic Gastritis and Colitis.
M. Oertli, D. B. Engler, E. Kohler, M. Koch, T. F. Meyer, and A. Muller (2011)
J. Immunol.
187, 3578-3586
|Abstract »|Full Text »|PDF »
From 'JUNK' to Just Unexplored Noncoding Knowledge: the case of transcribed Alus.
R. Pandey and M. Mukerji (2011)
Briefings in Functional Genomics
10, 294-311
|Abstract »|Full Text »|PDF »
MicroRNA Regulation of Molecular Networks Mapped by Global MicroRNA, mRNA, and Protein Expression in Activated T Lymphocytes.
Y. A. Grigoryev, S. M. Kurian, T. Hart, A. A. Nakorchevsky, C. Chen, D. Campbell, S. R. Head, J. R. Yates III, and D. R. Salomon (2011)
J. Immunol.
187, 2233-2243
|Abstract »|Full Text »|PDF »
Oncogenic IRFs Provide a Survival Advantage for Epstein-Barr Virus- or Human T-Cell Leukemia Virus Type 1-Transformed Cells through Induction of BIC Expression.
L. Wang, N. L. Toomey, L. A. Diaz, G. Walker, J. C. Ramos, G. N. Barber, and S. Ning (2011)
J. Virol.
85, 8328-8337
|Abstract »|Full Text »|PDF »
MicroRNA Expression Profiles of Human Blood Monocyte-derived Dendritic Cells and Macrophages Reveal miR-511 as Putative Positive Regulator of Toll-like Receptor 4.
L. Tserel, T. Runnel, K. Kisand, M. Pihlap, L. Bakhoff, R. Kolde, H. Peterson, J. Vilo, P. Peterson, and A. Rebane (2011)
J. Biol. Chem.
286, 26487-26495
|Abstract »|Full Text »|PDF »
Signature microRNA Expression Profile of Essential Hypertension and Its Novel Link to Human Cytomegalovirus Infection.
S. Li, J. Zhu, W. Zhang, Y. Chen, K. Zhang, L. M. Popescu, X. Ma, W. Bond Lau, R. Rong, X. Yu, et al. (2011)
Circulation
124, 175-184
|Abstract »|Full Text »|PDF »
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis.
M. Kurowska-Stolarska, S. Alivernini, L. E. Ballantine, D. L. Asquith, N. L. Millar, D. S. Gilchrist, J. Reilly, M. Ierna, A. R. Fraser, B. Stolarski, et al. (2011)
PNAS
108, 11193-11198
|Abstract »|Full Text »|PDF »
MicroRNA-155 is involved in the remodelling of human-trophoblast-derived HTR-8/SVneo cells induced by lipopolysaccharides.
Y. Dai, Z. Diao, H. Sun, R. Li, Z. Qiu, and Y. Hu (2011)
Hum. Reprod.
26, 1882-1891
|Abstract »|Full Text »|PDF »
A detailed investigation of accessibilities around target sites of siRNAs and miRNAs.
H. Kiryu, G. Terai, O. Imamura, H. Yoneyama, K. Suzuki, and K. Asai (2011)
Bioinformatics
27, 1788-1797
|Abstract »|Full Text »|PDF »
Novel Therapeutic Options in Anaplastic Large Cell Lymphoma: Molecular Targets and Immunological Tools.
O. Merkel, F. Hamacher, E. Sifft, L. Kenner, R. Greil, and for the European Research Initiative on Anaplastic (2011)
Mol. Cancer Ther.
10, 1127-1136
|Abstract »|Full Text »|PDF »
miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice.
M. P. Boldin, K. D. Taganov, D. S. Rao, L. Yang, J. L. Zhao, M. Kalwani, Y. Garcia-Flores, M. Luong, A. Devrekanli, J. Xu, et al. (2011)
J. Exp. Med.
208, 1189-1201
|Abstract »|Full Text »|PDF »
MicroRNAs and their roles in mammalian stem cells.
Differential MicroRNA Expression in Experimental Cerebral and Noncerebral Malaria.
F. El-Assaad, C. Hempel, V. Combes, A. J. Mitchell, H. J. Ball, J. A. L. Kurtzhals, N. H. Hunt, J.-M. Mathys, and G. E. R. Grau (2011)
Infect. Immun.
79, 2379-2384
|Abstract »|Full Text »|PDF »
MiRNA in innate immune responses: novel players in wound inflammation.
Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function.
I. Dunand-Sauthier, M.-L. Santiago-Raber, L. Capponi, C. E. Vejnar, O. Schaad, M. Irla, Q. Seguin-Estevez, P. Descombes, E. M. Zdobnov, H. Acha-Orbea, et al. (2011)
Blood
117, 4490-4500
|Abstract »|Full Text »|PDF »
miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1.
C. Lu, X. Huang, X. Zhang, K. Roensch, Q. Cao, K. I. Nakayama, B. R. Blazar, Y. Zeng, and X. Zhou (2011)
Blood
117, 4293-4303
|Abstract »|Full Text »|PDF »
Evidence That the Lipid Phosphatase SHIP-1 Regulates T Lymphocyte Morphology and Motility.
S. J. Harris, R. V. Parry, J. G. Foster, M. D. Blunt, A. Wang, F. Marelli-Berg, J. Westwick, and S. G. Ward (2011)
J. Immunol.
186, 4936-4945
|Abstract »|Full Text »|PDF »
Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL.
X. Li, T. Sanda, A. T. Look, C. D. Novina, and H. von Boehmer (2011)
J. Exp. Med.
208, 663-675
|Abstract »|Full Text »|PDF »
Dynamic BRG1 Recruitment during T Helper Differentiation and Activation Reveals Distal Regulatory Elements.
S. De, A. L. Wurster, P. Precht, W. H. Wood III, K. G. Becker, and M. J. Pazin (2011)
Mol. Cell. Biol.
31, 1512-1527
|Abstract »|Full Text »|PDF »
Dynamic Changes of microRNAs in the Eye during the Development of Experimental Autoimmune Uveoretinitis.
W. Ishida, K. Fukuda, T. Higuchi, M. Kajisako, S. Sakamoto, and A. Fukushima (2011)
Invest. Ophthalmol. Vis. Sci.
52, 611-617
|Abstract »|Full Text »|PDF »
Insulin Up-Regulates Heme Oxygenase-1 Expression in 3T3-L1 Adipocytes via PI3-Kinase- and PKC-Dependent Pathways and Heme Oxygenase-1-Associated MicroRNA Downregulation.
C.-L. Chang, L.-C. Au, S.-W. Huang, C. Fai Kwok, L.-T. Ho, and C.-C. Juan (2011)
Endocrinology
152, 384-393
|Abstract »|Full Text »|PDF »
NF-{kappa}B Down-regulates Expression of the B-lymphoma Marker CD10 through a miR-155/PU.1 Pathway.
R. C. Thompson, M. Herscovitch, I. Zhao, T. J. Ford, and T. D. Gilmore (2011)
J. Biol. Chem.
286, 1675-1682
|Abstract »|Full Text »|PDF »
The Interleukin 13 (IL-13) Pathway in Human Macrophages Is Modulated by MicroRNA-155 via Direct Targeting of Interleukin 13 Receptor {alpha}1 (IL13R{alpha}1).
R. T. Martinez-Nunez, F. Louafi, and T. Sanchez-Elsner (2011)
J. Biol. Chem.
286, 1786-1794
|Abstract »|Full Text »|PDF »
Up-regulation of MicroRNA-155 in Macrophages Contributes to Increased Tumor Necrosis Factor {alpha} (TNF{alpha}) Production via Increased mRNA Half-life in Alcoholic Liver Disease.
S. Bala, M. Marcos, K. Kodys, T. Csak, D. Catalano, P. Mandrekar, and G. Szabo (2011)
J. Biol. Chem.
286, 1436-1444
|Abstract »|Full Text »|PDF »
MicroRNA-148/152 Impair Innate Response and Antigen Presentation of TLR-Triggered Dendritic Cells by Targeting CaMKII{alpha}.
X. Liu, Z. Zhan, L. Xu, F. Ma, D. Li, Z. Guo, N. Li, and X. Cao (2010)
J. Immunol.
185, 7244-7251
|Abstract »|Full Text »|PDF »
Virally Induced Cellular MicroRNA miR-155 Plays a Key Role in B-Cell Immortalization by Epstein-Barr Virus.
S. D. Linnstaedt, E. Gottwein, R. L. Skalsky, M. A. Luftig, and B. R. Cullen (2010)
J. Virol.
84, 11670-11678
|Abstract »|Full Text »|PDF »
Inducible microRNA-155 Feedback Promotes Type I IFN Signaling in Antiviral Innate Immunity by Targeting Suppressor of Cytokine Signaling 1.
P. Wang, J. Hou, L. Lin, C. Wang, X. Liu, D. Li, F. Ma, Z. Wang, and X. Cao (2010)
J. Immunol.
185, 6226-6233
|Abstract »|Full Text »|PDF »
Next-generation sequencing identifies the natural killer cell microRNA transcriptome.
T. A. Fehniger, T. Wylie, E. Germino, J. W. Leong, V. J. Magrini, S. Koul, C. R. Keppel, S. E. Schneider, D. C. Koboldt, R. P. Sullivan, et al. (2010)
Genome Res.
20, 1590-1604
|Abstract »|Full Text »|PDF »
Analysis of microRNA knockouts in mice.
C. Y. Park, Y. S. Choi, and M. T. McManus (2010)
Hum. Mol. Genet.
19, R169-R175
|Abstract »|Full Text »|PDF »
Regulation of WNK1 Expression by miR-192 and Aldosterone.
E. Elvira-Matelot, X.-o. Zhou, N. Farman, G. Beaurain, A. Henrion-Caude, J. Hadchouel, and X. Jeunemaitre (2010)
J. Am. Soc. Nephrol.
21, 1724-1731
|Abstract »|Full Text »|PDF »
Proinflammatory Role for let-7 MicroRNAS in Experimental Asthma.
S. Polikepahad, J. M. Knight, A. O. Naghavi, T. Oplt, C. J. Creighton, C. Shaw, A. L. Benham, J. Kim, B. Soibam, R. A. Harris, et al. (2010)
J. Biol. Chem.
285, 30139-30149
|Abstract »|Full Text »|PDF »
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.
O. Merkel, F. Hamacher, D. Laimer, E. Sifft, Z. Trajanoski, M. Scheideler, G. Egger, M. R. Hassler, C. Thallinger, A. Schmatz, et al. (2010)
PNAS
107, 16228-16233
|Abstract »|Full Text »|PDF »
miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate.
M. Mann, O. Barad, R. Agami, B. Geiger, and E. Hornstein (2010)
PNAS
107, 15804-15809
|Abstract »|Full Text »|PDF »
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD.
E. Tili, J.-J. Michaille, B. Adair, H. Alder, E. Limagne, C. Taccioli, M. Ferracin, D. Delmas, N. Latruffe, and C. M. Croce (2010)
Carcinogenesis
31, 1561-1566
|Abstract »|Full Text »|PDF »
Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors.
L. F. Sempere, M. Preis, T. Yezefski, H. Ouyang, A. A. Suriawinata, A. Silahtaroglu, J. R. Conejo-Garcia, S. Kauppinen, W. Wells, and M. Korc (2010)
Clin. Cancer Res.
16, 4246-4255
|Abstract »|Full Text »|PDF »
Transcriptome and targetome analysis in MIR155 expressing cells using RNA-seq.
G. Xu, C. Fewell, C. Taylor, N. Deng, D. Hedges, X. Wang, K. Zhang, M. Lacey, H. Zhang, Q. Yin, et al. (2010)
RNA
16, 1610-1622
|Abstract »|Full Text »|PDF »
IL-10 Inhibits miR-155 Induction by Toll-like Receptors.
C. E. McCoy, F. J. Sheedy, J. E. Qualls, S. L. Doyle, S. R. Quinn, P. J. Murray, and L. A. J. O'Neill (2010)
J. Biol. Chem.
285, 20492-20498
|Abstract »|Full Text »|PDF »
MicroRNA miR-155 Inhibits Bone Morphogenetic Protein (BMP) Signaling and BMP-Mediated Epstein-Barr Virus Reactivation.
Q. Yin, X. Wang, C. Fewell, J. Cameron, H. Zhu, M. Baddoo, Z. Lin, and E. K. Flemington (2010)
J. Virol.
84, 6318-6327
|Abstract »|Full Text »|PDF »
Efficient inhibition of miR-155 function in vivo by peptide nucleic acids.
M. M. Fabani, C. Abreu-Goodger, D. Williams, P. A. Lyons, A. G. Torres, K. G. C. Smith, A. J. Enright, M. J. Gait, and E. Vigorito (2010)
Nucleic Acids Res.
38, 4466-4475
|Abstract »|Full Text »|PDF »
MicroRNA 125b inhibition of B cell differentiation in germinal centers.
M. Gururajan, C. L. Haga, S. Das, C.-M. Leu, D. Hodson, S. Josson, M. Turner, and M. D. Cooper (2010)
Int. Immunol.
22, 583-592
|Abstract »|Full Text »|PDF »
CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells.
S. Rom, I. Rom, G. Passiatore, M. Pacifici, S. Radhakrishnan, L. Del Valle, S. Pina-Oviedo, K. Khalili, D. Eletto, and F. Peruzzi (2010)
FASEB J
24, 2292-2300
|Abstract »|Full Text »|PDF »